Anatomic correction of all the components of the syndrome of prolapsing right coronary cusp, dilatation of the sinus of Valsalva, and ventricular septal defect, can be achieved by a very simple technique. This technique can be applied in young children and prevents progression and secondary changes. Early correction in all patients with this syndrome is warranted.
Although the pulmonary autograft requires a significantly longer operating time, this does not seem to affect early and medium-term outcome when compared with results obtained with aortic homografts. Continued patient evaluation is warranted, particularly with regard to evidence of valve degeneration and right ventricular function and arrhythmias in the long term.
Background and aim of the study: Aim of this study is to compare the incidence of postoperative bleeding events, identified as pericardial effusion, for those patients undergoing cardiac surgery and discharged on vitamin K antagonist (VKA) versus those discharged on NOACs. Methods: This was a retrospective observational cohort study; from July 2017 to July 2019, all the patients who underwent any cardiac surgical procedure and discharged on any oral anticoagulant, were rolled in the study. The study variables and setting followed the STROBE checklist. The final cohort was constituted by 382 patients (mean age 70±11.2 years); 260(68.1%) patients were discharged on VKA and 122(31.9%) were discharged on NOACs. The primary end point was the incidence of major postoperative bleeding, defined as pericardial effusion requiring surgical re-exploration. The key secondary composite end point was the late re-admission for pericardial effusion. Results: The overall incidence of in-hospital immediate bleeding events, with need of re-exploration for pericardial effusion, was 4.7% (n=18). The incidence of re-admission for pericardial effusion was 3.1% (n=12). Eight of those patients had surgical re-exploration: four patients were discharged on NOACs and the remnant four ones were discharged on VKA. No significant relationships were observed between the different oral anticoagulants and the incidence of pericardial effusion, at any time. No ischemic and thromboembolic events were recorded. Conclusions: The use of non-vitamin K antagonist oral anticoagulant, in post cardiac surgery patients, does not increase the incidence of major bleeding events, intended as immediate or late pericardial effusion.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.